paclitaxel analogs (BTG)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namepaclitaxel analogs (BTG)
Drug Alias Name2-Debenzoyl-2-(3,5-difluorobenzoyl)taxol (BTG)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule stabilizer
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBTG USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBTG USA IncVirginia Polytechnic Institute and State University
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A